Navigation Links
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
Date:12/3/2008

- Tasigna front-line data demonstrating potential in newly diagnosed patients with a life-threatening type of leukemia to be featured in two oral sessions at ASH

- Exjade results at ASH to show benefits for chronically transfused patients by significantly reducing toxic iron that can damage key organs

- New long-term data from major independent breast cancer trial at SABCS to report on optimal post-surgery treatment strategy, Femara vs. tamoxifen

- Multiple Zometa studies at SABCS to affirm anti-cancer activity in patients with early-stage breast cancer

EAST HANOVER, N.J., Dec. 4 /PRNewswire/ -- More than 200 abstracts from therapies across the Novartis Oncology portfolio will be presented at two December medical congresses, providing new data and profiling potential patient benefits from ongoing collaboration with the oncology community.

The American Society of Hematology (ASH) annual meeting, beginning December 6th in San Francisco, CA, will feature 34 oral presentations on the Novartis Oncology portfolio including 20 on Gleevec(R) (imatinib mesylate) tablets, six on Tasigna(R) (nilotinib) capsules, five on Exjade(R) (deferasirox) and three on products in development. The CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), beginning December 10th, will feature four oral presentations, including three on Femara(R) (letrozole tablets) and one on Zometa(R) (zoledronic acid) injection.

"Our robust portfolio and dedication to oncology research is ultimately about providing patients and their physicians with new treatment options to address unmet medical needs," said David Epstein, CEO and President of Novartis Oncology. "We are pleased that our ongoing work with experts in the fields of oncology and hematology continue to provide valuable new insights across multiple cancer types."

The most significant presentations
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
4. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
5. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
6. Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. New Conflict of Interest Violations Revealed at California Stem Cell Institute
9. St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia
10. Protein Tomography(TM) Reveals Molecular Mode of Action of Humax-EGFr Published in PNAS
11. Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... SAN DIEGO , May 17, 2013 /PRNewswire/ ... today that its Fast-Track Advanced Technology Small Business ... National Institute of Allergy and Infectious Diseases (NIAID), ... (NIH), supporting the development of novel human antibody ... S. aureus or Staph) infections, including methicillin-resistant ...
(Date:5/17/2013)... CHAMPAIGN, Ill. , May 17, 2013  Sony ... new Sony SP6800 Spectral Analyzer (SP6800).  Sony will be ... 2013, which will be held at the ... San Diego, California , from May 20 - ... Sony,s second analytical system, incorporating commercial audio-visual technologies into ...
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- The ... recombinant proteins, is placing renewed emphasis on alternate ... rise as a number of factors are converging ... pharmaceutical makers and their delivery device partners . ... refractory conditions, the growing trend toward self-administration for ...
Breaking Medicine Technology:Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3
... Fla., Oct. 20, 2011 China Nuvo Solar Energy, ... Nevada has approved the Company,s requested corporate name change to ... and authorized the Board of Directors to change the Company,s ... of the Parent. As a result of the Nevada approval, ...
... FREMONT, Calif., Oct. 20, 2011 WaferGen Biosystems, ... announced organizational changes to strengthen domain leadership and ... of its SmartChip System.   As ... Lombardi, formerly President and a director of Helicos ...
Cached Medicine Technology:China Nuvo Solar, Inc. Announces Corporate Name Change to SurgLine International, Inc. 2WaferGen Announces Organizational Changes to Enhance Commercialization of SmartChip System 2WaferGen Announces Organizational Changes to Enhance Commercialization of SmartChip System 3
(Date:5/20/2013)... York, NY (PRWEB) May 20, 2013 ... York City, today announced the introduction of its new ... powder that provides high density nutrition with plant extracts ... vegetables, herbs, spices, royal jelly, apple pectin, plant enzymes ... Hx™ offers the micronutrients and antioxidant levels of several ...
(Date:5/20/2013)... Hills, Utah (PRWEB) May 20, 2013 As a ... can be to effectively balance family, work, and a fit, healthy ... weight gain. , “It hit me like a ton of bricks ... Arnold. “I woke up one morning and realized I had lost ... time. I felt awful, I had little to no energy to ...
(Date:5/19/2013)... New York, NY (PRWEB) May 20, 2013 ... announce that they are representing a New York woman in ... running back with the National Football League (NFL). According ... Court, the Petitioner is seeking a declaration of paternity, order ... on behalf of her son with Mr. Walker. (Docket ...
(Date:5/19/2013)... Calif., May 20, 2013 Whole-cell pertussis vaccines ... acellular pertussis vaccines during a large recent outbreak, ... in Pediatrics . , Whole-cell pertussis vaccines, ... to 1990s, but were associated with safety concerns ... pertussis vaccines, which are also called DTaP. By ...
(Date:5/19/2013)... Alonso Krangle LLP a dedicated law ... lawsuit on behalf of a-24-year-old financial analyst rendered quadriplegic ... The diving accident lawsuit, which was filed in the Supreme ... Defendant held the property out as a bathing beach, but ... area. (Case No. 34556/12) , According to the diving accident ...
Breaking Medicine News(10 mins):Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 2Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 3Health News:New Program Helps Busy Moms Become Healthier, Lose Weight, and Feel Great 2Health News:New York Woman in Paternity Petition Against Former NFL Running Back, Herschel Walker, Alonso Krangle LLP Representing Petitioner 2Health News:New York Woman in Paternity Petition Against Former NFL Running Back, Herschel Walker, Alonso Krangle LLP Representing Petitioner 3Health News:Whole-cell vaccine was more effective than acellular vaccine during CA pertussis outbreak 2Health News:Whole-cell vaccine was more effective than acellular vaccine during CA pertussis outbreak 3Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 2Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 3
... Ulagu”,Wondering what the above verses from Thirukurral written by ... special report about nanotechnology? // , ,“ Annuvai ... the ingenuity of its author, that he has compressed ... as if he had hollowed an atom, and enclosed ...
... proposes to change the curriculum for medicine by integrating ... within two years., ,"Today's medical curriculum is ... the modern and traditional practices in the new curriculum. ... time," said health minister, Ramadoss during National Seminar on ...
... men and occurs in men 65 years or older. It ... should undergo the routine examination of prostate and also test ... levels of PSA in blood. African-American men or men with ... screening exams at an earlier age. Signs and symptoms of ...
... that more and more women are now opting for ... new study in the September issue of the journal ... delivery become more varied and sophisticated, growing numbers of ... childbirth., ,Researchers from the University of Colorado had ...
... acne for more than six weeks were more than ... infection within one year as individuals with acne who ... study reports., ,Overuse of antibiotics has been held ... increase in increase in infectious illness. The present study ...
... is a genetic disorder characterized by distorted, sickle shaped red ... and organ damage to the kidneys, spleen, and liver. The ... the incidence is about 1 in 500., ,Despite much ... disease. Pain can be relieved, and the frequency and duration ...
Cached Medicine News:Health News:Scientists Consider About New Technology Called Nanotechnology 2Health News:Hydroxyurea Treatment For Children With Sickle Cell Disease 2
An immunochromatographic test for detection of 4 species of Plasmodium antigen ( P. falciparum , P. vivax , P. malariae , P. ovale ) in whole blood....
Malaria device / strip (3 line, PAN-pLDH, P.f.-HRP2)...
... Biotech Uni-Gold™ Pf Malaria Test is ... the presence of Plasmodium falciparum ... is an antigen-capture assay detecting presence ... rich protein II (PfHRP- II), which ...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Medicine Products: